← Back to patent-cliff list
琥珀酸美托洛尔
Tier C — Watch / tradeMetoprolol Succinate
Aralez Pharma
Originator
1985
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：ADRB1
Brand：Spesicor Dos、Toprol XL
Indications (approved)：高血压、心绞痛、心脏衰竭、甲状腺功能亢进症、心律失常、心脏神经官能症
Regional status
US
批准上市
1992-01-10
EU
临床三期
2021-08-18
China
批准上市
1985-01-01
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Metoprolol Succinate?
Approved indications include: 高血压, 心绞痛, 心脏衰竭, 甲状腺功能亢进症, 心律失常, 心脏神经官能症.
When does the Metoprolol Succinate patent expire?
No public expiry year is available for Metoprolol Succinate yet; this page updates once verified.
How do I get a quote for Metoprolol Succinate intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-25